Global Pet Weight Loss Drugs Market Research Report 2026

Pet Weight Loss Drugs Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pet Weight Loss Drugs competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Pet weight loss drugs refer to medications used for the management of overweight and obesity in dogs, cats, and other companion animals, as well as veterinary-guided weight management functional preparations. Their goals are to reduce body fat and weight, improve body condition scores (BCS), and reduce the risk of obesity-related complications. Product forms typically include oral solutions, tablets/capsules, soft chewable tablets, and powder strips; their mechanisms of action may include inhibiting fat absorption and transport, regulating appetite and energy intake, and improving metabolism and gut microbiota. From the demand side, the number of cats owned by urban households in China is large, but there are currently no approved prescription weight loss drugs, leaving the market untapped and offering a significant first-mover advantage. From a willingness-to-pay perspective, pet owners in first-tier and new first-tier cities spend an average of 2,000-3,000 yuan annually on medical care, showing a high acceptance of high-value-added products. Furthermore, obesity in cats easily leads to complications such as diabetes and arthritis, making treatment relatively inelastic. Regarding pet owners' acceptance of weight loss drugs, awareness education is a key bottleneck. Secondly, the usage scenarios are limited by the penetration rate of medical services; currently, only a small number of pets undergo regular checkups, restricting drug accessibility. However, whether it can achieve large-scale sales depends on three hurdles: pricing (if a single course of treatment is too expensive, most owners will opt to "skip a few meals"), education (pet hospitals and owners need to be convinced that "medication + diet management" is safer and more effective than simply dieting), and education. Most companies are currently in the research and development stage.

Pet obesity is rapidly shifting from a "feeding habit problem" to a "quantifiable health management problem." Rising companion animal healthcare spending and changes in the pet population's demographics are expanding weight management goals beyond simple weight loss to include joint reduction, improved metabolic indicators, and control of chronic disease risks. For brands, the value of weight-loss drugs and weight management formulations lies not only in individual product sales but also in forming repurchaseable, customized solutions that combine them with weight management food, body condition assessments, follow-up visits, and exercise and feeding plans, resulting in more stable lifetime revenue.

On the supply side, the limited number of prescription anti-obesity drugs specifically for pets, coupled with high compliance and safety requirements, along with owner compliance and weight rebound issues, makes it difficult to scale up the "single-drug solution" approach. Therefore, the market is more likely to expand along two lines: one is the trend towards lighter prescriptions and e-commerce, primarily using supplements and functional formulations, emphasizing safety boundaries and long-term use; the other is veterinarian-centric prescription and solution-based approaches, creating tiered management around high-risk dogs and cats, and improving sustainability through digital follow-up and subscription-based supplementation.

The structural trend on the demand side is that weight management is increasingly resembling a cross-category service-oriented consumption. Consumers are more willing to pay for visible improvements in their physical condition, and the distribution channels will see a combination of "online repurchase and replenishment plus offline veterinary assessment." At the same time, competition surrounding the scientific evidence for formulations, clinical follow-up data, and real-world effects will intensify significantly, and products lacking evidence or making exaggerated claims will face higher compliance and reputation risks.

This report delivers a comprehensive overview of the global Pet Weight Loss Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pet Weight Loss Drugs. The Pet Weight Loss Drugs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Pet Weight Loss Drugs market comprehensively. Regional market sizes by Type, by Application, by Pet, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Pet Weight Loss Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Pet Weight Loss Drugs Market Report

Chapter Outline

1.1 Product Definition

1.2 Pet Weight Loss Drugs by Type

1.2.1 Global Pet Weight Loss Drugs Market Value by Type: 2025 vs 2032

1.2.2 Injectables

1.2.3 Oral Medications

1.2.4 Others

1.3 Pet Weight Loss Drugs by Pet

1.3.1 Global Pet Weight Loss Drugs Market Value by Pet: 2025 vs 2032

1.3.2 Dogs

1.3.3 Cats

1.3.4 Others

1.4 Pet Weight Loss Drugs by Property

1.4.1 Global Pet Weight Loss Drugs Market Value by Property: 2025 vs 2032

1.4.2 Medicines

1.4.3 Supplements

1.5 Pet Weight Loss Drugs by Application

1.5.1 Global Pet Weight Loss Drugs Market Value by Application: 2025 vs 2032

1.5.2 Pet Hospital

1.5.3 Clinic

1.6 Global Pet Weight Loss Drugs Market Size Estimates and Forecasts

1.6.1 Global Pet Weight Loss Drugs Revenue 2021–2032

1.6.2 Global Pet Weight Loss Drugs Sales 2021–2032

1.6.3 Global Pet Weight Loss Drugs Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2.1 Global Pet Weight Loss Drugs Sales Market Share by Manufacturers (2021–2026)

2.2 Global Pet Weight Loss Drugs Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Pet Weight Loss Drugs Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Pet Weight Loss Drugs, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Pet Weight Loss Drugs, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Pet Weight Loss Drugs, Product Types and Applications

2.7 Global Key Manufacturers of Pet Weight Loss Drugs, Date of Entry into the Industry

2.8 Global Pet Weight Loss Drugs Market Competitive Situation and Trends

2.8.1 Global Pet Weight Loss Drugs Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Pet Weight Loss Drugs Players Market Share by Revenue

2.8.3 Global Pet Weight Loss Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Pet Weight Loss Drugs Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Pet Weight Loss Drugs Sales by Region: 2021–2032

3.2.1 Global Pet Weight Loss Drugs Sales by Region: 2021–2026

3.2.2 Global Pet Weight Loss Drugs Sales by Region: 2027–2032

3.3 Global Pet Weight Loss Drugs Revenue by Region: 2021–2032

3.3.1 Global Pet Weight Loss Drugs Revenue by Region: 2021–2026

3.3.2 Global Pet Weight Loss Drugs Revenue by Region: 2027–2032

3.4 North America Pet Weight Loss Drugs Market Facts & Figures by Country

3.4.1 North America Pet Weight Loss Drugs Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Pet Weight Loss Drugs Sales by Country (2021–2032)

3.4.3 North America Pet Weight Loss Drugs Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Pet Weight Loss Drugs Market Facts & Figures by Country

3.5.1 Europe Pet Weight Loss Drugs Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Pet Weight Loss Drugs Sales by Country (2021–2032)

3.5.3 Europe Pet Weight Loss Drugs Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pet Weight Loss Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Pet Weight Loss Drugs Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Pet Weight Loss Drugs Sales by Region (2021–2032)

3.6.3 Asia Pacific Pet Weight Loss Drugs Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Pet Weight Loss Drugs Market Facts & Figures by Country

3.7.1 Latin America Pet Weight Loss Drugs Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Pet Weight Loss Drugs Sales by Country (2021–2032)

3.7.3 Latin America Pet Weight Loss Drugs Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Pet Weight Loss Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Pet Weight Loss Drugs Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Pet Weight Loss Drugs Sales by Country (2021–2032)

3.8.3 Middle East and Africa Pet Weight Loss Drugs Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Pet Weight Loss Drugs Sales by Type (2021–2032)

4.1.1 Global Pet Weight Loss Drugs Sales by Type (2021–2026)

4.1.2 Global Pet Weight Loss Drugs Sales by Type (2027–2032)

4.1.3 Global Pet Weight Loss Drugs Sales Market Share by Type (2021–2032)

4.2 Global Pet Weight Loss Drugs Revenue by Type (2021–2032)

4.2.1 Global Pet Weight Loss Drugs Revenue by Type (2021–2026)

4.2.2 Global Pet Weight Loss Drugs Revenue by Type (2027–2032)

4.2.3 Global Pet Weight Loss Drugs Revenue Market Share by Type (2021–2032)

4.3 Global Pet Weight Loss Drugs Price by Type (2021–2032)

5.1 Global Pet Weight Loss Drugs Sales by Application (2021–2032)

5.1.1 Global Pet Weight Loss Drugs Sales by Application (2021–2026)

5.1.2 Global Pet Weight Loss Drugs Sales by Application (2027–2032)

5.1.3 Global Pet Weight Loss Drugs Sales Market Share by Application (2021–2032)

5.2 Global Pet Weight Loss Drugs Revenue by Application (2021–2032)

5.2.1 Global Pet Weight Loss Drugs Revenue by Application (2021–2026)

5.2.2 Global Pet Weight Loss Drugs Revenue by Application (2027–2032)

5.2.3 Global Pet Weight Loss Drugs Revenue Market Share by Application (2021–2032)

5.3 Global Pet Weight Loss Drugs Price by Application (2021–2032)

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Pet Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Pfizer Pet Weight Loss Drugs Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Zoetis

6.2.1 Zoetis Company Information

6.2.2 Zoetis Description and Business Overview

6.2.3 Zoetis Pet Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Zoetis Pet Weight Loss Drugs Product Portfolio

6.2.5 Zoetis Recent Developments/Updates

6.3 Okava Pharmaceuticals

6.3.1 Okava Pharmaceuticals Company Information

6.3.2 Okava Pharmaceuticals Description and Business Overview

6.3.3 Okava Pharmaceuticals Pet Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Okava Pharmaceuticals Pet Weight Loss Drugs Product Portfolio

6.3.5 Okava Pharmaceuticals Recent Developments/Updates

6.4 Omni Pet

6.4.1 Omni Pet Company Information

6.4.2 Omni Pet Description and Business Overview

6.4.3 Omni Pet Pet Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Omni Pet Pet Weight Loss Drugs Product Portfolio

6.4.5 Omni Pet Recent Developments/Updates

6.5 Better Choice Company (BTTR)

6.5.1 Better Choice Company (BTTR) Company Information

6.5.2 Better Choice Company (BTTR) Description and Business Overview

6.5.3 Better Choice Company (BTTR) Pet Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Better Choice Company (BTTR) Pet Weight Loss Drugs Product Portfolio

6.5.5 Better Choice Company (BTTR) Recent Developments/Updates

6.6 Orion Pharma

6.6.1 Orion Pharma Company Information

6.6.2 Orion Pharma Description and Business Overview

6.6.3 Orion Pharma Pet Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Orion Pharma Pet Weight Loss Drugs Product Portfolio

6.6.5 Orion Pharma Recent Developments/Updates

6.7 Rooted Owl

6.7.1 Rooted Owl Company Information

6.7.2 Rooted Owl Description and Business Overview

6.7.3 Rooted Owl Pet Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Rooted Owl Pet Weight Loss Drugs Product Portfolio

6.7.5 Rooted Owl Recent Developments/Updates

6.8 Huadong Medicine Co., Ltd.

6.8.1 Huadong Medicine Co., Ltd. Company Information

6.8.2 Huadong Medicine Co., Ltd. Description and Business Overview

6.8.3 Huadong Medicine Co., Ltd. Pet Weight Loss Drugs Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Huadong Medicine Co., Ltd. Pet Weight Loss Drugs Product Portfolio

6.8.5 Huadong Medicine Co., Ltd. Recent Developments/Updates

7.1 Pet Weight Loss Drugs Industry Chain Analysis

7.2 Pet Weight Loss Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pet Weight Loss Drugs Production Mode & Process Analysis

7.4 Pet Weight Loss Drugs Sales and Marketing

7.4.1 Pet Weight Loss Drugs Sales Channels

7.4.2 Pet Weight Loss Drugs Distributors

7.5 Pet Weight Loss Drugs Customer Analysis

8.1 Pet Weight Loss Drugs Industry Trends

8.2 Pet Weight Loss Drugs Market Drivers

8.3 Pet Weight Loss Drugs Market Challenges

8.4 Pet Weight Loss Drugs Market Restraints

8.5 Impact of U.S. Tariffs

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

 Table 1. Global Pet Weight Loss Drugs Market Value by Type (US$ Million), 2025 vs 2032

 Table 2. Global Pet Weight Loss Drugs Market Value by Pet (US$ Million), 2025 vs 2032

 Table 3. Global Pet Weight Loss Drugs Market Value by Property (US$ Million), 2025 vs 2032

 Table 4. Global Pet Weight Loss Drugs Market Value by Application (US$ Million), 2025 vs 2032

 Table 5. Global Pet Weight Loss Drugs Market Competitive Situation by Manufacturers in 2025

 Table 6. Global Pet Weight Loss Drugs Sales (K Units) of Key Manufacturers (2021–2026)

 Table 7. Global Pet Weight Loss Drugs Sales Market Share by Manufacturers (2021–2026)

 Table 8. Global Pet Weight Loss Drugs Revenue (US$ Million) by Manufacturers (2021–2026)

 Table 9. Global Pet Weight Loss Drugs Revenue Share by Manufacturers (2021–2026)

 Table 10. Global Market Pet Weight Loss Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)

 Table 11. Global Key Players of Pet Weight Loss Drugs, Industry Ranking, 2023 vs 2024 vs 2025

 Table 12. Global Key Manufacturers of Pet Weight Loss Drugs, Manufacturing Sites and Headquarters

 Table 13. Global Key Manufacturers of Pet Weight Loss Drugs, Product Types and Applications

 Table 14. Global Key Manufacturers of Pet Weight Loss Drugs, Date of Entry into the Industry

 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

 Table 16. Global Pet Weight Loss Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pet Weight Loss Drugs Revenue, 2025

 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

 Table 18. Global Pet Weight Loss Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 19. Global Pet Weight Loss Drugs Sales by Region (K Units), 2021–2026

 Table 20. Global Pet Weight Loss Drugs Sales Market Share by Region (2021–2026)

 Table 21. Global Pet Weight Loss Drugs Sales by Region (K Units), 2027–2032

 Table 22. Global Pet Weight Loss Drugs Sales Market Share by Region (2027–2032)

 Table 23. Global Pet Weight Loss Drugs Revenue by Region (US$ Million), 2021–2026

 Table 24. Global Pet Weight Loss Drugs Revenue Market Share by Region (2021–2026)

 Table 25. Global Pet Weight Loss Drugs Revenue by Region (US$ Million), 2027–2032

 Table 26. Global Pet Weight Loss Drugs Revenue Market Share by Region (2027–2032)

 Table 27. North America Pet Weight Loss Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 28. North America Pet Weight Loss Drugs Sales by Country (K Units), 2021–2026

 Table 29. North America Pet Weight Loss Drugs Sales by Country (K Units), 2027–2032

 Table 30. North America Pet Weight Loss Drugs Revenue by Country (US$ Million), 2021–2026

 Table 31. North America Pet Weight Loss Drugs Revenue by Country (US$ Million), 2027–2032

 Table 32. Europe Pet Weight Loss Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 33. Europe Pet Weight Loss Drugs Sales by Country (K Units), 2021–2026

 Table 34. Europe Pet Weight Loss Drugs Sales by Country (K Units), 2027–2032

 Table 35. Europe Pet Weight Loss Drugs Revenue by Country (US$ Million), 2021–2026

 Table 36. Europe Pet Weight Loss Drugs Revenue by Country (US$ Million), 2027–2032

 Table 37. Asia Pacific Pet Weight Loss Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

 Table 38. Asia Pacific Pet Weight Loss Drugs Sales by Region (K Units), 2021–2026

 Table 39. Asia Pacific Pet Weight Loss Drugs Sales by Region (K Units), 2027–2032

 Table 40. Asia Pacific Pet Weight Loss Drugs Revenue by Region (US$ Million), 2021–2026

 Table 41. Asia Pacific Pet Weight Loss Drugs Revenue by Region (US$ Million), 2027–2032

 Table 42. Latin America Pet Weight Loss Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 43. Latin America Pet Weight Loss Drugs Sales by Country (K Units), 2021–2026

 Table 44. Latin America Pet Weight Loss Drugs Sales by Country (K Units), 2027–2032

 Table 45. Latin America Pet Weight Loss Drugs Revenue by Country (US$ Million), 2021–2026

 Table 46. Latin America Pet Weight Loss Drugs Revenue by Country (US$ Million), 2027–2032

 Table 47. Middle East and Africa Pet Weight Loss Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 48. Middle East and Africa Pet Weight Loss Drugs Sales by Country (K Units), 2021–2026

 Table 49. Middle East and Africa Pet Weight Loss Drugs Sales by Country (K Units), 2027–2032

 Table 50. Middle East and Africa Pet Weight Loss Drugs Revenue by Country (US$ Million), 2021–2026

 Table 51. Middle East and Africa Pet Weight Loss Drugs Revenue by Country (US$ Million), 2027–2032

 Table 52. Global Pet Weight Loss Drugs Sales (K Units) by Type (2021–2026)

 Table 53. Global Pet Weight Loss Drugs Sales (K Units) by Type (2027–2032)

 Table 54. Global Pet Weight Loss Drugs Sales Market Share by Type (2021–2026)

 Table 55. Global Pet Weight Loss Drugs Sales Market Share by Type (2027–2032)

 Table 56. Global Pet Weight Loss Drugs Revenue (US$ Million) by Type (2021–2026)

 Table 57. Global Pet Weight Loss Drugs Revenue (US$ Million) by Type (2027–2032)

 Table 58. Global Pet Weight Loss Drugs Revenue Market Share by Type (2021–2026)

 Table 59. Global Pet Weight Loss Drugs Revenue Market Share by Type (2027–2032)

 Table 60. Global Pet Weight Loss Drugs Price (US$/Unit) by Type (2021–2026)

 Table 61. Global Pet Weight Loss Drugs Price (US$/Unit) by Type (2027–2032)

 Table 62. Global Pet Weight Loss Drugs Sales (K Units) by Application (2021–2026)

 Table 63. Global Pet Weight Loss Drugs Sales (K Units) by Application (2027–2032)

 Table 64. Global Pet Weight Loss Drugs Sales Market Share by Application (2021–2026)

 Table 65. Global Pet Weight Loss Drugs Sales Market Share by Application (2027–2032)

 Table 66. Global Pet Weight Loss Drugs Revenue (US$ Million) by Application (2021–2026)

 Table 67. Global Pet Weight Loss Drugs Revenue (US$ Million) by Application (2027–2032)

 Table 68. Global Pet Weight Loss Drugs Revenue Market Share by Application (2021–2026)

 Table 69. Global Pet Weight Loss Drugs Revenue Market Share by Application (2027–2032)

 Table 70. Global Pet Weight Loss Drugs Price (US$/Unit) by Application (2021–2026)

 Table 71. Global Pet Weight Loss Drugs Price (US$/Unit) by Application (2027–2032)

 Table 72. Pfizer Company Information

 Table 73. Pfizer Description and Business Overview

 Table 74. Pfizer Pet Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 75. Pfizer Pet Weight Loss Drugs Product

 Table 76. Pfizer Recent Developments/Updates

 Table 77. Zoetis Company Information

 Table 78. Zoetis Description and Business Overview

 Table 79. Zoetis Pet Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 80. Zoetis Pet Weight Loss Drugs Product

 Table 81. Zoetis Recent Developments/Updates

 Table 82. Okava Pharmaceuticals Company Information

 Table 83. Okava Pharmaceuticals Description and Business Overview

 Table 84. Okava Pharmaceuticals Pet Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 85. Okava Pharmaceuticals Pet Weight Loss Drugs Product

 Table 86. Okava Pharmaceuticals Recent Developments/Updates

 Table 87. Omni Pet Company Information

 Table 88. Omni Pet Description and Business Overview

 Table 89. Omni Pet Pet Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 90. Omni Pet Pet Weight Loss Drugs Product

 Table 91. Omni Pet Recent Developments/Updates

 Table 92. Better Choice Company (BTTR) Company Information

 Table 93. Better Choice Company (BTTR) Description and Business Overview

 Table 94. Better Choice Company (BTTR) Pet Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 95. Better Choice Company (BTTR) Pet Weight Loss Drugs Product

 Table 96. Better Choice Company (BTTR) Recent Developments/Updates

 Table 97. Orion Pharma Company Information

 Table 98. Orion Pharma Description and Business Overview

 Table 99. Orion Pharma Pet Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 100. Orion Pharma Pet Weight Loss Drugs Product

 Table 101. Orion Pharma Recent Developments/Updates

 Table 102. Rooted Owl Company Information

 Table 103. Rooted Owl Description and Business Overview

 Table 104. Rooted Owl Pet Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 105. Rooted Owl Pet Weight Loss Drugs Product

 Table 106. Rooted Owl Recent Developments/Updates

 Table 107. Huadong Medicine Co., Ltd. Company Information

 Table 108. Huadong Medicine Co., Ltd. Description and Business Overview

 Table 109. Huadong Medicine Co., Ltd. Pet Weight Loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 110. Huadong Medicine Co., Ltd. Pet Weight Loss Drugs Product

 Table 111. Huadong Medicine Co., Ltd. Recent Developments/Updates

 Table 112. Key Raw Materials Lists

 Table 113. Raw Materials Key Suppliers Lists

 Table 114. Pet Weight Loss Drugs Distributors List

 Table 115. Pet Weight Loss Drugs Customers List

 Table 116. Pet Weight Loss Drugs Market Trends

 Table 117. Pet Weight Loss Drugs Market Drivers

 Table 118. Pet Weight Loss Drugs Market Challenges

 Table 119. Pet Weight Loss Drugs Market Restraints

 Table 120. Research Programs/Design for This Report

 Table 121. Key Data Information from Secondary Sources

 Table 122. Key Data Information from Primary Sources

 Table 123. Authors List of This Report

List of Figures

 Figure 1. Product Picture of Pet Weight Loss Drugs

 Figure 2. Global Pet Weight Loss Drugs Market Value by Type (US$ Million), 2021–2032

 Figure 3. Global Pet Weight Loss Drugs Market Share by Type: 2025 & 2032

 Figure 4. Injectables Product Picture

 Figure 5. Oral Medications Product Picture

 Figure 6. Others Product Picture

 Figure 7. Global Pet Weight Loss Drugs Market Value by Pet (US$ Million), 2021–2032

 Figure 8. Global Pet Weight Loss Drugs Market Share by Pet: 2025 vs 2032

 Figure 9. Dogs Product Picture

 Figure 10. Cats Product Picture

 Figure 11. Others Product Picture

 Figure 12. Global Pet Weight Loss Drugs Market Value by Property (US$ Million), 2021–2032

 Figure 13. Global Pet Weight Loss Drugs Market Share by Property: 2025 vs 2032

 Figure 14. Medicines Product Picture

 Figure 15. Supplements Product Picture

 Figure 16. Global Pet Weight Loss Drugs Market Value by Application (US$ Million), 2021–2032

 Figure 17. Global Pet Weight Loss Drugs Market Share by Application: 2025 & 2032

 Figure 18. Pet Hospital

 Figure 19. Clinic

 Figure 20. Global Pet Weight Loss Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032

 Figure 21. Global Pet Weight Loss Drugs Market Size (US$ Million), 2021–2032

 Figure 22. Global Pet Weight Loss Drugs Sales (K Units), 2021–2032

 Figure 23. Global Pet Weight Loss Drugs Average Price (US$/Unit), 2021–2032

 Figure 24. Pet Weight Loss Drugs Report Years Considered

 Figure 25. Pet Weight Loss Drugs Sales Share by Manufacturers in 2025

 Figure 26. Global Pet Weight Loss Drugs Revenue Share by Manufacturers in 2025

 Figure 27. Top 5 and Top 10 Global Pet Weight Loss Drugs Players: Market Share by Revenue in Pet Weight Loss Drugs in 2025

 Figure 28. Pet Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

 Figure 29. Global Pet Weight Loss Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Figure 30. North America Pet Weight Loss Drugs Sales Market Share by Country (2021–2032)

 Figure 31. North America Pet Weight Loss Drugs Revenue Market Share by Country (2021–2032)

 Figure 32. United States Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 33. Canada Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 34. Europe Pet Weight Loss Drugs Sales Market Share by Country (2021–2032)

 Figure 35. Europe Pet Weight Loss Drugs Revenue Market Share by Country (2021–2032)

 Figure 36. Germany Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 37. France Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 38. U.K. Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 39. Italy Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 40. Russia Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 41. Asia Pacific Pet Weight Loss Drugs Sales Market Share by Region (2021–2032)

 Figure 42. Asia Pacific Pet Weight Loss Drugs Revenue Market Share by Region (2021–2032)

 Figure 43. China Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 44. Japan Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 45. South Korea Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 46. India Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 47. Australia Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 48. China Taiwan Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 49. Southeast Asia Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 50. Latin America Pet Weight Loss Drugs Sales Market Share by Country (2021–2032)

 Figure 51. Latin America Pet Weight Loss Drugs Revenue Market Share by Country (2021–2032)

 Figure 52. Mexico Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 53. Brazil Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 54. Argentina Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 55. Colombia Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 56. Middle East and Africa Pet Weight Loss Drugs Sales Market Share by Country (2021–2032)

 Figure 57. Middle East and Africa Pet Weight Loss Drugs Revenue Market Share by Country (2021–2032)

 Figure 58. Turkey Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 59. Saudi Arabia Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 60. UAE Pet Weight Loss Drugs Revenue Growth Rate (US$ Million), 2021–2032

 Figure 61. Global Sales Market Share of Pet Weight Loss Drugs by Type (2021–2032)

 Figure 62. Global Revenue Market Share of Pet Weight Loss Drugs by Type (2021–2032)

 Figure 63. Global Pet Weight Loss Drugs Price (US$/Unit) by Type (2021–2032)

 Figure 64. Global Sales Market Share of Pet Weight Loss Drugs by Application (2021–2032)

 Figure 65. Global Revenue Market Share of Pet Weight Loss Drugs by Application (2021–2032)

 Figure 66. Global Pet Weight Loss Drugs Price (US$/Unit) by Application (2021–2032)

 Figure 67. Pet Weight Loss Drugs Value Chain

 Figure 68. Channels of Distribution (Direct Vs Distribution)

 Figure 69. Bottom-up and Top-down Approaches for This Report

 Figure 70. Data Triangulation

 Figure 71. Key Executives Interviewed